Circulating microRNAs as a Fingerprint for Liver Cirrhosis
Yanjie Chen(Chongqing Medical University), Xizhong Shen(Shanghai Medical College of Fudan University), Xiaoling Guo(Shanghai University of Traditional Chinese Medicine), Jie Hu(Zhongshan Hospital), Jian Zhou(Hainan Medical University), Hao Wu(Stanford Medicine), Ji‐Min Zhu(Fudan University), Jia Fan(Fudan University), Taotao Liu(Zhongshan Hospital), Qian Yu(Fudan University), Xiaowu Huang(Fudan University), Lei Yang(Fudan University), Chunlei Wu(Scripps Research Institute)
Cited by 69
Related Papers
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|977
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828